N (%) | |
---|---|
Patients enrolled and fully evaluable | 74 (100) |
Age, median value (range, IQR) | 72 (49–82, 67–77) |
ECOG Performance Status | |
0–1 | 55 (74.3) |
2 | 19 (25.7) |
Gleason score | |
< 8 | 14 (22.2) |
≥8 | 49 (77.8) |
Unknown/missing | 11 |
Bone mts | 72 (97.3) |
Visceral mts | 11 (15.1) |
Liver mts | 6 (8.2) |
Lymph node mts | 42 (57.5) |
Presence of pain | 25 (36.8) |
Previous surgery (radical prostatectomy) | 33 (44.6) |
Previous radiotherapy (radical radiotherapy) | 32 (43.2) |
Number of previous treatments | |
1 | 17 (23) |
2 | 43 (58.1) |
3 | 14 (18.9) |
AR CN | |
Normal | 40 (54.0) |
Gain | 34 (46.0) |
Alkaline Phosphatase U/l, median value (range, IQR) | 174 (54–965, 101–270) |
Lactate Dehydrogenase U/l, median value (range, IQR) | 240 (76–1177, 181–345) |
Hemoglobin g/l, median value (range, IQR) | 12.0 (9.0–15.0, 10.9–13.1) |
Neutrophils count, median value (range, IQR) | 4150 (840–8730, 3100–5360) |
Lymphocytes count, median value (range, IQR) | 1495 (90–26,000, 1120–1900) |
Platelets count, median value (range, IQR) | 236,000 (115,000–719,000, 196,000–295,000) |
Serum Albumin g/l, median value (range, IQR) | 31.3 (3.7–42.0, 4.0–40.0) |
PSA, median value (range, IQR) | 54.56 (2.69–5000, 19–175.60) |